Deena Shakir (@deenashakir) 's Twitter Profile
Deena Shakir

@deenashakir

General Partner @Lux_Capital | Investing in 🚀 like @mavenclinic, @alifeivf, @joinsummer, @steadymd, @waymark_care, @tryramp, @triallibrary | mom of 3

ID: 129063594

linkhttp://deenashakir.com calendar_today03-04-2010 02:26:30

11,11K Tweet

32,32K Followers

1,1K Following

Lux Capital (@lux_capital) 's Twitter Profile Photo

6/ Clinical AI is just getting started but is evolving at breakneck speed. This patient-centered tech is moving swiftly from "early stage" to "prime time," with adoption rates soaring in a matter of weeks.

Lux Capital (@lux_capital) 's Twitter Profile Photo

7/ AI's indirect perks for patients are undeniable: streamlined documentation and swift claims processing. It's enhancing patient experiences without the need for direct engagement.

Lux Capital (@lux_capital) 's Twitter Profile Photo

8/ Incentives matter: Adoption hinges on aligned incentives - across health systems, pharma, and regulators. That’s why partnerships like Epic x @Abridgehq are gaining traction.

Lux Capital (@lux_capital) 's Twitter Profile Photo

9/ AI isn't sidelining the human touch in healthcare; it's supercharging it. By enhancing care and boosting efficiency, AI supports rather than replaces the vital clinician-patient bond. After all, healthcare is inherently human.

Deena Shakir (@deenashakir) 's Twitter Profile Photo

👇 Matt Grimm is absolutely right. I love to invest in startup founders who are parents. It forces ruthless prioritization, savvy negotiation skills, the art of listening... I wrote about it (for mothers specifically, but true for both) a few years back: forbes.com/sites/deenasha…

Matthew Herper (@matthewherper) 's Twitter Profile Photo

What do some of the top thinkers in biotech and healthcare hope? And what do they fear? We got to ask that of speakers and attendees at last week's #STATBreakthrough conference. Hear their answers, on everything from AI to funding of science, from speakers including biotech

STAT (@statnews) 's Twitter Profile Photo

What do some of the top thinkers in biotech and healthcare hope? And what do they fear? We got to ask that of speakers and attendees at last week's #STATBreakthrough conference. Hear their answers, on everything from AI to funding of science, from speakers including biotech

Lawrence H. Summers (@lhsummers) 's Twitter Profile Photo

The Donald J. Trump Administration's vendetta action against Harvard is now over the top. It is crazy to make enemies of thousands of the most talented young people from around the world. This violates the norms of decency and fairness and will make us a poorer country and, in

Ro Khanna (@rokhanna) 's Twitter Profile Photo

Anyone from Silicon Valley willing to speak out against the Trump JD Vance ban on current and future international students at Harvard? I know Elon Musk David Sacks Marc Andreessen 🇺🇸 Chamath Palihapitiya Vinod Khosla Reid Hoffman that there is not a single tech leader who can defend this on the merits.

Deena Shakir (@deenashakir) 's Twitter Profile Photo

I’ve loved Coldplay since I was a teen. Tonight, in a packed stadium at Stanford, my Arab-American heart swelled as the talented Palestinian Elyanna performed with them—in Arabic, and Chris Martin thanked her with “Shukran.” A surreal moment of hope when it’s sorely needed.

I’ve loved <a href="/coldplay/">Coldplay</a> since I was a teen. Tonight, in a packed stadium at Stanford, my Arab-American heart swelled as the talented Palestinian <a href="/Elyanna/">Elyanna</a> performed with them—in Arabic, and Chris Martin thanked her with “Shukran.” A surreal moment of hope when it’s sorely needed.
Peter Hebert (@peterjhebert) 's Twitter Profile Photo

The magic of eGenesis: turning science fiction (employing gene editing + genome engineering to transplant pig kidneys into human beings) into everyday "life" boston25news.com/news/local/nh-…

Eric Glyman (@eglyman) 's Twitter Profile Photo

Today, Ramp reached a new valuation: $16 billion Let the robots chase your receipts and close your books, so you can use your brain and build things. That's the way AI was meant to be.

Today, <a href="/tryramp/">Ramp</a> reached a new valuation: $16 billion

Let the robots chase your receipts and close your books, so you can use your brain and build things.

That's the way AI was meant to be.
Danny Crichton (@dannycrichton) 's Twitter Profile Photo

Applied Intuition is one of the best-run companies in the Valley, and so it should surprise no one that it's now racing through decacorn valuations. Great product, happy customers, and a brilliant technical roadmap are all part of the story: bloomberg.com/news/articles/…

Deena Shakir (@deenashakir) 's Twitter Profile Photo

I've known Eric Glyman and Karim Atiyeh since college and through their early Paribus days, and they have never ceased to impress me; world class execution. Today, Ramp is a $16B company. Proud to have Lux Capital along for the ride--the best is yet to come!

Karim Atiyeh (@karimatiyeh) 's Twitter Profile Photo

2 thoughts on Ramp’s new $16B valuation: 1) We’re growing faster than ever and somehow also shipping faster than ever 2) We’re powering finance for the fastest-growing AI companies in the world 👇

2 thoughts on <a href="/tryramp/">Ramp</a>’s new $16B valuation:

1) We’re growing faster than ever and somehow also shipping faster than ever
2) We’re powering finance for the fastest-growing AI companies in the world 👇
Sami Shalabi (@shalabi) 's Twitter Profile Photo

Proud to share that we’ve raised a total of $78M so far! The round was led by Dell Technologies Capital, with participation from Cisco Investments, SE Ventures (backed by Schneider Electric), and continued support from Lux Capital, M13, and E14 Fund This signals that our